These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2576370)

  • 21. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adynamic ileus, its pathogenesis and treatment.
    Furness JB; Costa M
    Med Biol; 1974 Apr; 52(2):82-9. PubMed ID: 4365867
    [No Abstract]   [Full Text] [Related]  

  • 23. Prokinetic agents in postgastrectomy patients.
    Patterson DJ
    Gastroenterol Clin North Am; 1994 Jun; 23(2):313-25. PubMed ID: 7915253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bethanechol for neonatal transient gastrointestinal dismotility in two cases of congenital myotonic dystrophy].
    Matsui K; Yamashita S; Shibasaki J; Watanabe T
    No To Hattatsu; 2007 Jul; 39(4):304-8. PubMed ID: 17633090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs coordinating and restoring gastrointestinal motility and their effect on selected hypodynamic gastrointestinal disorders in horses and cattle.
    Steiner A; Roussel AJ
    Zentralbl Veterinarmed A; 1995 Dec; 42(10):613-31. PubMed ID: 8822186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility.
    Briejer MR; Akkermans LM; Schuurkes JA
    Pharmacol Rev; 1995 Dec; 47(4):631-51. PubMed ID: 8746557
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
    Weber FH; Richards RD; McCallum RW
    Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of intestinal stimulatory effects of 5-hydroxytryptamine by adrenergic amines, prostaglandin E1 and theophylline.
    Grubb MN; Burks TF
    J Pharmacol Exp Ther; 1974 May; 189(2):476-83. PubMed ID: 4364199
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of endogenous opioids in the control of gastrointestinal motility: predictions from in vitro modelling.
    Sanger GJ; Tuladhar BR
    Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():38-45. PubMed ID: 15357850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract.
    Hiyama T; Yoshihara M; Tanaka S; Haruma K; Chayama K
    J Gastroenterol Hepatol; 2009 Apr; 24(4):537-46. PubMed ID: 19220673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access options for withdrawn motility-modifying agents.
    Jones MP
    Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atropine, bethanechol, and esophageal motility.
    Russell CO; Korman MG
    Gastroenterology; 1982 Aug; 83(2):519-20. PubMed ID: 6123467
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholinergic effects on esophageal transit and clearance.
    Phaosawasdi K; Malmud LS; Tolin RD; Stelzer F; Applegate G; Fisher RS
    Gastroenterology; 1981 Nov; 81(5):915-20. PubMed ID: 7286570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal motility following vagotomy and the use of urecholine for the control of certain undesirable phenomena.
    MACHELLA TE; LORBER SH
    Gastroenterology; 1948 Oct; 11(4):426-41. PubMed ID: 18888102
    [No Abstract]   [Full Text] [Related]  

  • 37. Intestinal peptides and their relevance in pediatric disease.
    Carvajal SH; Mulvihill SJ
    Semin Pediatr Surg; 1995 Feb; 4(1):9-21. PubMed ID: 7728511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method for studying the actions of drugs on motility of vascularly perfused segments of human colon.
    Burleigh DE; Levine DF; Motson RW
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):118-28. PubMed ID: 6440492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of emesis and gastrointestinal motility: implications for migraine.
    De Ponti F
    Funct Neurol; 2000; 15 Suppl 3():43-9. PubMed ID: 11200800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of the small intestinal pharmacoradiography].
    Watanabe S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1969 Dec; 29(9):1173-222. PubMed ID: 4392017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.